{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:00:52Z","timestamp":1793714452391,"version":"4.6.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s40266-019-00661-0","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T06:27:30Z","timestamp":1557383250000},"page":"45-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Safety of Topical Non-steroidal Anti-Inflammatory Drugs in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6992-6712","authenticated-orcid":false,"given":"Germain","family":"Honvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Geerinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Rabenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Beaudart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6290-752X","authenticated-orcid":false,"given":"Jean-Yves","family":"Reginster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4269-9393","authenticated-orcid":false,"given":"Olivier","family":"Bruy\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,9]]},"reference":[{"issue":"9783","key":"661_CR1","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(11)60243-2","volume":"377","author":"JW Bijlsma","year":"2011","unstructured":"Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377(9783):2115\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(11)60243-2 .","journal-title":"Lancet"},{"issue":"3","key":"661_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.semarthrit.2014.05.014","volume":"44","author":"O Bruyere","year":"2014","unstructured":"Bruyere O, Cooper C, Pelletier JP, Branco J, Brandi ML, Guillemin F, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44(3):253\u201363. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.05.014 .","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"661_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","volume":"22","author":"TE McAlindon","year":"2014","unstructured":"McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil. 2014;22(3):363\u201388. https:\/\/doi.org\/10.1016\/j.joca.2014.01.003 .","journal-title":"Osteoarthr Cartil"},{"issue":"4","key":"661_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.21596","volume":"64","author":"MC Hochberg","year":"2012","unstructured":"Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64(4):465\u201374. https:\/\/doi.org\/10.1002\/acr.21596 .","journal-title":"Arthritis Care Res"},{"key":"661_CR5","unstructured":"NICE. Osteoarthritis care and management in adults: methods, evidence and recommendations. National Clinical Guideline Centre. Report No. CG177. London: National Institute for Health and Care Excellence; 2014."},{"issue":"12","key":"661_CR6","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/ard.2003.011742","volume":"62","author":"KM Jordan","year":"2003","unstructured":"Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JWJ, Dieppe P, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62(12):1145\u201355. https:\/\/doi.org\/10.1136\/ard.2003.011742 .","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"661_CR7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","volume":"18","author":"W Zhang","year":"2010","unstructured":"Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartil. 2010;18(4):476\u201399. https:\/\/doi.org\/10.1016\/j.joca.2010.01.013 .","journal-title":"Osteoarthr Cartil"},{"key":"661_CR8","unstructured":"Chou R, McDonagh MS, Nakamoto E, Griffin J. Analgesics for osteoarthritis: an update of the 2006 comparative effectiveness review. Comparative effectiveness review no. 38. October 2011. AHRQ Publication No. 11(12)-EHC076-EF. Rockville: Agency for Healthcare Research and Quality. http:\/\/www.ncbi.nlm.nih.gov\/pubmedhealth\/PMH0016485\/pdf\/TOC.pdf . Accessed 27 Apr 2018."},{"issue":"6","key":"661_CR9","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3899\/jrheum.090935","volume":"37","author":"UE Makris","year":"2010","unstructured":"Makris UE, Kohler MJ, Fraenkel L. Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: a systematic literature review. J Rheumatol. 2010;37(6):1236\u201343. https:\/\/doi.org\/10.3899\/jrheum.090935 .","journal-title":"J Rheumatol"},{"key":"661_CR10","doi-asserted-by":"publisher","first-page":"CD007400","DOI":"10.1002\/14651858.cd007400.pub3","volume":"4","author":"S Derry","year":"2016","unstructured":"Derry S, Conaghan P, Da Silva JA, Wiffen PJ, Moore RA. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2016;4:CD007400. https:\/\/doi.org\/10.1002\/14651858.cd007400.pub3 .","journal-title":"Cochrane Database Syst Rev"},{"key":"661_CR11","doi-asserted-by":"publisher","first-page":"CD007400","DOI":"10.1002\/14651858.cd007400.pub2","volume":"9","author":"S Derry","year":"2012","unstructured":"Derry S, Moore RA, Rabbie R. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2012;9:CD007400. https:\/\/doi.org\/10.1002\/14651858.cd007400.pub2 .","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"661_CR12","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1136\/annrheumdis-2015-208387","volume":"75","author":"K Zou","year":"2016","unstructured":"Zou K, Wong J, Abdullah N, Chen X, Smith T, Doherty M, et al. Examination of overall treatment effect and the proportion attributable to contextual effect in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis. 2016;75(11):1964\u201370. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208387 .","journal-title":"Ann Rheum Dis"},{"key":"661_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2017-098043","author":"C Zeng","year":"2018","unstructured":"Zeng C, Wei J, Persson MSM, Sarmanova A, Doherty M, Xie D, et al. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies. Br J Sports Med. 2018. https:\/\/doi.org\/10.1136\/bjsports-2017-098043 .","journal-title":"Br J Sports Med"},{"key":"661_CR14","unstructured":"Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011. http:\/\/www.handbook.cochrane.org . Accessed 19 July 2018."},{"issue":"10","key":"661_CR15","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006\u201312. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.005 .","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"661_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"issue":"1","key":"661_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/sim.2528","volume":"26","author":"MJ Bradburn","year":"2007","unstructured":"Bradburn MJ, Deeks JJ, Berlin JA, Russell Localio A. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med. 2007;26(1):53\u201377. https:\/\/doi.org\/10.1002\/sim.2528 .","journal-title":"Stat Med"},{"issue":"29","key":"661_CR18","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1002\/sim.4040","volume":"29","author":"T Stijnen","year":"2010","unstructured":"Stijnen T, Hamza TH, Ozdemir P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. 2010;29(29):3046\u201367. https:\/\/doi.org\/10.1002\/sim.4040 .","journal-title":"Stat Med"},{"issue":"3","key":"661_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P","volume":"18","author":"SL Normand","year":"1999","unstructured":"Normand SL. Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med. 1999;18(3):321\u201359.","journal-title":"Stat Med"},{"issue":"7414","key":"661_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557 .","journal-title":"BMJ"},{"issue":"20","key":"661_CR21","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1002\/sim.2380","volume":"25","author":"RM Harbord","year":"2006","unstructured":"Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25(20):3443\u201357. https:\/\/doi.org\/10.1002\/sim.2380 .","journal-title":"Stat Med"},{"key":"661_CR22","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JA Sterne","year":"2011","unstructured":"Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002. https:\/\/doi.org\/10.1136\/bmj.d4002 .","journal-title":"BMJ"},{"issue":"7109","key":"661_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"4","key":"661_CR24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026 .","journal-title":"J Clin Epidemiol"},{"key":"661_CR25","unstructured":"GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (developed by Evidence Prime, Inc.). Available from gradepro.org. Evidence Prime, Inc."},{"issue":"1","key":"661_CR26","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1186\/ar2906","volume":"12","author":"HR Barthel","year":"2010","unstructured":"Barthel HR, Peniston JH, Clark MB, Gold MS, Altman RD. Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis. Arthritis Res Ther. 2010;12(1):R7. https:\/\/doi.org\/10.1186\/ar2906 .","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"661_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2165\/11584880-000000000-00000","volume":"28","author":"HS Baraf","year":"2011","unstructured":"Baraf HS, Gloth FM, Barthel HR, Gold MS, Altman RD. Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials. Drugs Aging. 2011;28(1):27\u201340. https:\/\/doi.org\/10.2165\/11584880-000000000-00000 .","journal-title":"Drugs Aging"},{"issue":"8","key":"661_CR28","first-page":"403","volume":"59","author":"A Allegrini","year":"2009","unstructured":"Allegrini A, Nuzzo L, Pavone D, Tavella-Scaringi A, Giangreco D, Bucci M, et al. Efficacy and safety of piroxicam patch versus piroxicam cream in patients with lumbar osteoarthritis. A randomized, placebo-controlled study. Arzneimittelforschung. 2009;59(8):403\u20139.","journal-title":"Arzneimittelforschung"},{"issue":"9","key":"661_CR29","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3899\/jrheum.081316","volume":"36","author":"RD Altman","year":"2009","unstructured":"Altman RD, Dreiser RL, Fisher CL, Chase WF, Dreher DS, Zacher J. Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009;36(9):1991\u20139. https:\/\/doi.org\/10.3899\/jrheum.081316 .","journal-title":"J Rheumatol"},{"key":"661_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2474-6-44","volume":"6","author":"PA Baer","year":"2005","unstructured":"Baer PA, Thomas LM, Shainhouse Z. Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]. BMC Musculoskelet Disord. 2005;6:44. https:\/\/doi.org\/10.1186\/1471-2474-6-44 .","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"661_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3810\/psm.2010.06.1779","volume":"38","author":"HS Baraf","year":"2010","unstructured":"Baraf HS, Gold MS, Clark MB, Altman RD. Safety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: a randomized controlled trial. Phys Sportsmed. 2010;38(2):19.","journal-title":"Phys Sportsmed"},{"issue":"3","key":"661_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.semarthrit.2009.09.002","volume":"39","author":"HR Barthel","year":"2009","unstructured":"Barthel HR, Haselwood D, Longley S, Gold MS, Altman RD. Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis. Semin Arthritis Rheum. 2009;39(3):203.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"661_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1503\/cmaj.1031793","volume":"171","author":"AA Bookman","year":"2004","unstructured":"Bookman AA, Williams KS, Shainhouse JZ. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ. 2004;171(4):333\u20138. https:\/\/doi.org\/10.1503\/cmaj.1031793 .","journal-title":"CMAJ"},{"issue":"2","key":"661_CR34","first-page":"193","volume":"21","author":"P Bruhlmann","year":"2003","unstructured":"Bruhlmann P, Michel BA. Topical diclofenac patch in patients with knee osteoarthritis: a randomized, double-blind, controlled clinical trial. Clin Exp Rheumatol. 2003;21(2):193\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"661_CR35","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/rheumatology\/ket133","volume":"52","author":"PG Conaghan","year":"2013","unstructured":"Conaghan PG, Dickson J, Bolten W, Cevc G, Rother M. A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Rheumatology (Oxf). 2013;52(7):1303\u201312. https:\/\/doi.org\/10.1093\/rheumatology\/ket133 .","journal-title":"Rheumatology (Oxf)"},{"issue":"3","key":"661_CR36","first-page":"117","volume":"19","author":"RL Dreiser","year":"1993","unstructured":"Dreiser RL, Tisne-Camus M. DHEP plasters as a topical treatment of knee osteoarthritis\u2014a double-blind placebo-controlled study. Drugs Exp Clin Res. 1993;19(3):117.","journal-title":"Drugs Exp Clin Res"},{"issue":"5","key":"661_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/RHU.0b013e318156b85f","volume":"13","author":"H Ergun","year":"2007","unstructured":"Ergun H, Kulcu D, Kutlay S, Bodur H, Tulunay FC. Efficacy and safety of topical nimesulide in the treatment of knee osteoarthritis. J Clin Rheumatol. 2007;13(5):251.","journal-title":"J Clin Rheumatol"},{"issue":"12","key":"661_CR38","first-page":"2659","volume":"26","author":"D Grace","year":"1999","unstructured":"Grace D, Rogers J, Skeith K, Anderson K. Topical diclofenac versus placebo: a double blind, randomized clinical trial in patients with osteoarthritis of the knee. J Rheumatol. 1999;26(12):2659.","journal-title":"J Rheumatol"},{"issue":"101540514","key":"661_CR39","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2147\/JPR.S51054","volume":"6","author":"W Kneer","year":"2013","unstructured":"Kneer W, Rother M, Mazgareanu S, Seidel EJ, European Idea-Study Group. A 12-week randomized study of topical therapy with three dosages of ketoprofen in Transfersome gel (IDEA-033) compared with the ketoprofen-free vehicle (TDT 064), in patients with osteoarthritis of the knee. J Pain Res. 2013;6(101540514):743\u201353. https:\/\/doi.org\/10.2147\/JPR.S51054 .","journal-title":"J Pain Res"},{"issue":"12","key":"661_CR40","first-page":"2384","volume":"32","author":"F Niethard","year":"2005","unstructured":"Niethard F, Gold MS, Solomon GS, Liu JM, Unkauf M, Albrecht HH, et al. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. J Rheumatol. 2005;32(12):2384.","journal-title":"J Rheumatol"},{"issue":"3","key":"661_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/joca.2000.0385","volume":"9","author":"B Ottillinger","year":"2001","unstructured":"Ottillinger B, Gomor B, Michel BA, Pavelka K, Beck W, Elsasser U. Efficacy and safety of eltenac gel in the treatment of knee osteoarthritis. Osteoarthr Cartil. 2001;9(3):273\u201380. https:\/\/doi.org\/10.1053\/joca.2000.0385 .","journal-title":"Osteoarthr Cartil"},{"issue":"18","key":"661_CR42","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1001\/archinte.164.18.2017","volume":"164","author":"SH Roth","year":"2004","unstructured":"Roth SH, Shainhouse JZ. Efficacy and safety of a topical diclofenac solution (pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med. 2004;164(18):2017\u201323.","journal-title":"Arch Intern Med"},{"issue":"10","key":"661_CR43","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3899\/jrheum.130192","volume":"40","author":"M Rother","year":"2013","unstructured":"Rother M, Conaghan PG. A randomized, double-blind, phase III trial in moderate osteoarthritis knee pain comparing topical ketoprofen gel with ketoprofen-free gel. J Rheumatol. 2013;40(10):1742\u20138. https:\/\/doi.org\/10.3899\/jrheum.130192 .","journal-title":"J Rheumatol"},{"issue":"9","key":"661_CR44","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1136\/ard.2006.065128","volume":"66","author":"M Rother","year":"2007","unstructured":"Rother M, Lavins BJ, Kneer W, Lehnhardt K, Seidel EJ, Mazgareanu S. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial. Ann Rheum Dis. 2007;66(9):1178\u201383. https:\/\/doi.org\/10.1136\/ard.2006.065128 .","journal-title":"Ann Rheum Dis"},{"issue":"5\u20136","key":"661_CR45","first-page":"209","volume":"27","author":"J Rovensky","year":"2001","unstructured":"Rovensky J, Micekova D, Gubzova Z, Fimmers R, Lenhard G, Vogtle-Junkert U, et al. Treatment of knee osteoarthritis with a topical non-steroidal antiinflammatory drug. Results of a randomized, double-blind, placebo-controlled study on the efficacy and safety of a 5% ibuprofen cream. Drugs Exp Clin Res. 2001;27(5\u20136):209.","journal-title":"Drugs Exp Clin Res"},{"issue":"4","key":"661_CR46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/03009749709105318","volume":"26","author":"J Sandelin","year":"1997","unstructured":"Sandelin J, Harilainen A, Crone H, Hamberg P, Forsskahl B, Tamelander G. Local NSAID gel (eltenac) in the treatment of osteoarthritis of the knee. A double blind study comparing eltenac with oral diclofenac and placebo gel. Scand J Rheumatol. 1997;26(4):287.","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"661_CR47","first-page":"565","volume":"31","author":"K Trnavsky","year":"2004","unstructured":"Trnavsky K, Fischer M, Vogtle-Junkert U, Schreyger F. Efficacy and safety of 5% ibuprofen cream treatment in knee osteoarthritis. Results of a randomized, double-blind, placebo-controlled study. J Rheumatol. 2004;31(3):565.","journal-title":"J Rheumatol"},{"issue":"6","key":"661_CR48","doi-asserted-by":"crossref","first-page":"E749","DOI":"10.36076\/ppj.2013\/16\/E749","volume":"16","author":"G Varadi","year":"2013","unstructured":"Varadi G, Zhu Z, Blattler T, Hosle M, Loher A, Pokorny R, et al. Randomized clinical trial evaluating transdermal ibuprofen for moderate to severe knee osteoarthritis. Pain Phys. 2013;16(6):E749.","journal-title":"Pain Phys"},{"issue":"2","key":"661_CR49","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1185\/03007995.2015.1113400","volume":"32","author":"LT Wadsworth","year":"2016","unstructured":"Wadsworth LT, Kent JD, Holt RJ. Efficacy and safety of diclofenac sodium 2% topical solution for osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled, 4\u00a0week study. Curr Med Res Opin. 2016;32(2):241.","journal-title":"Curr Med Res Opin"},{"key":"661_CR50","first-page":"867","volume":"10","author":"I Yataba","year":"2017","unstructured":"Yataba I, Otsuka N, Matsushita I, Matsumoto H, Hoshino Y. The efficacy and safety of s-flurbiprofen plaster in the treatment of knee osteoarthritis: a phase II, randomized, double-blind, placebo-controlled, dose-finding study. Mod Rheumatol. 2017;10:867.","journal-title":"Mod Rheumatol"},{"issue":"7461","key":"661_CR51","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1136\/bmj.38159.639028.7C","volume":"329","author":"J Lin","year":"2004","unstructured":"Lin J, Zhang W, Jones A, Doherty M. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ. 2004;329(7461):324. https:\/\/doi.org\/10.1136\/bmj.38159.639028.7C .","journal-title":"BMJ"},{"issue":"3","key":"661_CR52","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2165\/00003495-200060030-00004","volume":"60","author":"CA Heyneman","year":"2000","unstructured":"Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs. 2000;60(3):555\u201374.","journal-title":"Drugs"},{"issue":"5","key":"661_CR53","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s10067-015-3021-z","volume":"35","author":"ZH Deng","year":"2016","unstructured":"Deng ZH, Zeng C, Yang Y, Li YS, Wei J, Yang T, et al. Topical diclofenac therapy for osteoarthritis: a meta-analysis of randomized controlled trials. Clin Rheumatol. 2016;35(5):1253\u201361. https:\/\/doi.org\/10.1007\/s10067-015-3021-z .","journal-title":"Clin Rheumatol"},{"issue":"2","key":"661_CR54","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/msc.1163","volume":"15","author":"V Sardana","year":"2017","unstructured":"Sardana V, Burzynski J, Zalzal P. Safety and efficacy of topical ketoprofen in transfersome gel in knee osteoarthritis: a systematic review. Musculoskelet Care. 2017;15(2):114\u201321. https:\/\/doi.org\/10.1002\/msc.1163 .","journal-title":"Musculoskelet Care"},{"issue":"16","key":"661_CR55","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1001\/archinternmed.2010.305","volume":"170","author":"R De Caterina","year":"2010","unstructured":"De Caterina R, Ruigomez A, Rodriguez LA. Long-term use of anti-inflammatory drugs and risk of atrial fibrillation. Arch Intern Med. 2010;170(16):1450\u20135. https:\/\/doi.org\/10.1001\/archinternmed.2010.305 .","journal-title":"Arch Intern Med"},{"key":"661_CR56","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1741-7015-3-17","volume":"3","author":"LA Garcia Rodriguez","year":"2005","unstructured":"Garcia Rodriguez LA, Gonzalez-Perez A. Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. BMC Med. 2005;3:17. https:\/\/doi.org\/10.1186\/1741-7015-3-17 .","journal-title":"BMC Med"},{"issue":"9","key":"661_CR57","first-page":"24","volume":"18","author":"ZA Marcum","year":"2010","unstructured":"Marcum ZA, Hanlon JT. Recognizing the risks of chronic nonsteroidal anti-inflammatory drug use in older adults. Ann Longterm Care. 2010;18(9):24\u20137.","journal-title":"Ann Longterm Care"},{"issue":"3","key":"661_CR58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3810\/psm.2011.09.1918","volume":"39","author":"JH Peniston","year":"2011","unstructured":"Peniston JH, Gold MS, Alwine LK. An open-label, long-term safety and tolerability trial of diclofenac sodium 1% gel in patients with knee osteoarthritis. Phys Sportsmed. 2011;39(3):31\u20138. https:\/\/doi.org\/10.3810\/psm.2011.09.1918 .","journal-title":"Phys Sportsmed"},{"key":"661_CR59","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2147\/CIA.S35416","volume":"7","author":"JH Peniston","year":"2012","unstructured":"Peniston JH, Gold MS, Wieman MS, Alwine LK. Long-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities. Clin Interv Aging. 2012;7:517\u201323. https:\/\/doi.org\/10.2147\/CIA.S35416 .","journal-title":"Clin Interv Aging"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-019-00661-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-019-00661-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-019-00661-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T14:19:55Z","timestamp":1663424395000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-019-00661-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":59,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["661"],"URL":"https:\/\/doi.org\/10.1007\/s40266-019-00661-0","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"9 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval of the version to be published.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Germain Honvo was funded by the ESCEO, a Belgian not-for-profit organization, and the ESCEO Working Group was entirely funded by the ESCEO. The ESCEO receives unrestricted educational grants, to support its educational and scientific activities, from non-governmental organizations, not-for-profit organizations, and non-commercial and corporate partners. The choice of topics, participants, content and agenda of the working groups, as well as the writing, editing, submission and reviewing of the manuscript, are under the sole responsibility of the ESCEO, without any influence from third parties.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Role of the Funding Source"}},{"value":"Olivier Bruy\u00e8re reports grants from Biophytis, IBSA, MEDA, Servier, SMB and Theramex, outside of the submitted work. Cyrus Cooper reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda and UCB, outside of the submitted work. Jean-Yves Reginster reports grants from IBSA-Genevrier, Mylan, CNIEL and Radius Health (through institution); consulting fees from IBSA-Genevrier, Mylan, CNIEL, Radius Health and Pierre Fabre; fees for participation in review activities from IBSA-Genevrier, MYLAN, CNIEL, Radius Health and Teva; and payment for lectures from AgNovos, CERIN, CNIEL, Dairy Research Council (DRC), Echolight, IBSA-Genevrier, Mylan, Pfizer Consumer Health, Teva and Theramex, outside of the submitted work. Thierry Thomas reports personal fees from Abbvie, Amgen, Arrow, BMS, Chugai, Expanscience, Gilead, HAC-Pharma, LCA, Lilly, Medac, MSD, Pfizer, Thuasne, TEVA and UCB, and grants from Amgen, Bone Therapeutics, Chugai, HAC-Pharma, MSD, Novartis, Pfizer and UCB, outside of the submitted work. Germain Honvo, Nicola Veronese, Victoria Leclercq, Anton Geerinck, Alexia Charles, Charlotte Beaudart and V\u00e9ronique Rabenda have no disclosures to report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}